Email: cspc@cspc.cn
Media
News Center
Sep. 08
2026
VOLUNTARY ANNOUNCEMENT - INNOVATIVE CHEMICAL DRUG SYH2083 EYE DROPS OBTAIN CLINICAL TRIAL APPROVAL IN CHINA
Sep. 07
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2085 TABLETS FOR THE TREATMENT OF UNCOMPLICATED INFLUENZA IN ADULTS OFFICIALLY INITIATED IN CHINA
Sep. 01
VOLUNTARY ANNOUNCEMENT - SYS6010 GRANTED ANOTHER BREAKTHROUGH THERAPY DESIGNATION BY THE NMPA IN CHINA FOR THE TREATMENT OF PATIENTS WITH RECURRENT OR METASTATI
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF SYH2056 TABLETS FOR THE TREATMENT OF DEPRESSION OFFICIALLY INITIATED IN CHINA
Aug. 31
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF SYH2092 INJECTION FOR WEIGHT MANAGEMENT IN ADULT PATIENTS WITH OVERWEIGHT OR OBESITY OFFICIALLY INITIATED AT
Aug. 28
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2069 INJECTION FOR WEIGHT MANAGEMENT IN ADULT PATIENTS WITH OVERWEIGHT OR OBESITY OFFICIALLY INITIATED AT
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us